---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-059225"
form_type: "8-K"
ticker: "FORA"
cik: "0001829280"
company_name: "Forian Inc."
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T08:12:19.092687+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Forian subsidiary amends data license deal; extends term to 2031, removes revenue share fees

## Summary
- Amendment adds 2014-2023 historical data product for a one-time payment; extends term with two additional renewal options through 2031.
- Annual license fee increased; all revenue share fees eliminated going forward.
- Vendor retains right to decline the final two-year renewal if it no longer licenses similar data to third parties.
- Other terms of original 2019 License Agreement remain unchanged.

## SEC filing metadata
- accession: 0001140361-23-059225
- form_type: 8-K
- ticker: FORA
- cik: 0001829280
- company_name: Forian Inc.
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829280/000114036123059225/0001140361-23-059225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829280/000114036123059225/ef20017235_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-059225
- JSON: https://secwatch.observer/filing/0001140361-23-059225.json
- Plain text: https://secwatch.observer/filing/0001140361-23-059225.txt

## Key facts
- Material Agreements
  Forian Inc. amended Second Amendment to License Agreement with third-party data provider (the "Vendor") valued at License fee increased; revenue share fees removed; renewal terms added: one additional year (first) (effective 2023-12-20).
  - Action: amendment
  - Agreement: license
  - Counterparty: third-party data provider (the "Vendor")
  - Value: License fee increased; revenue share fees removed; renewal terms added: one additional year (first)
  - Effective: 2023-12-20
  source text: On December 20, 2023, a subsidiary of Forian Inc., Medical Outcomes Research Analytics, LLC (together, the "Company"), entered into a second amendment (the "Amendment") to that certain License Agreement, dated of as of June 30, 2019 (the "License Agreement"), between the Company and a third-party data provider (the "Vendor") in order to, among other things, (a) provide for the Company's licensure of additional information assets; (b) modify the terms of use of such information assets; (c) extend the term of the License Agreement to include two additional renewal terms (the first for one additional year and the second for two additional years, each at the Company's election); and (d) modify the license fees relating to such information assets to increase the annual license fee and to remove all revenue share fees.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036123059225/0001140361-23-059225-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.